&Partners’s BlackRock ESG Capital Allocation Term Trust ECAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$416K Buy
26,465
+1,003
+4% +$15.1K ﹤0.01% 1947
2026
Q1
$346K Buy
25,462
+1,001
+4% +$15K ﹤0.01% 1898
2025
Q4
$376K Buy
+24,461
New +$392K ﹤0.01% 1778
2024
Q3
Sell
-10,353
Closed -$182K 1394
2024
Q2
$182K Buy
+10,353
New +$176K 0.01% 859

Other funds holding ECAT

&Partners's ECAT Position: Q2 2026 in Review

&Partners increased its BlackRock ESG Capital Allocation Term Trust (ECAT) stake by 3.9% in Q2 2026, buying an estimated $15.1K and bringing the position to 26,465 shares worth $416K. The position accounts for ﹤0.01% of the portfolio, ranked #1947.

&Partners first reported a position in ECAT in Q2 2024 and has held it in 4 quarters since. 79 funds tracked by Wall St. Rank hold ECAT as of Q2 2026.

  • &Partners held 26,465 shares of BlackRock ESG Capital Allocation Term Trust worth $416K as of Q2 2026.
  • &Partners bought 1,003 BlackRock ESG Capital Allocation Term Trust shares in Q2 2026, an estimated $15.1K.
  • BlackRock ESG Capital Allocation Term Trust made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1947 holding.
  • &Partners first reported a position in BlackRock ESG Capital Allocation Term Trust in Q2 2024 and has held it in 4 quarters since.
  • 79 funds tracked by Wall St. Rank held BlackRock ESG Capital Allocation Term Trust as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.